Completed from United Kingdom
The Advanced Drug Economics Certificate exceeded my expectations. The curriculum aligned perfectly with my goal to specialise in health‑technology assessment, and the modules on cost‑effectiveness modelling gave me a solid framework to apply in my current role at a NHS Trust. I particularly appreciated the case‑study workbook, which walked us through a full incremental cost‑effectiveness ratio calculation using real‑world data. The teaching materials were up‑to‑date, with references to the latest NICE guidelines, and the interactive webinars facilitated a deep dive into budget‑impact analysis. Overall, the programme was professionally delivered, the assessments were rigorous yet fair, and I now feel confident presenting economic evaluations to senior decision‑makers.
I loved the vibe of the Advanced Drug Economics course – it was exactly what I needed to boost my resume. The lessons on willingness‑to‑pay thresholds and Markov modelling were super clear, and the hands‑on Excel templates let me build a simple model for a new oncology drug in just a weekend. The course packs were packed with real‑world examples from both pharma and payer perspectives, which made the theory feel relevant to my work at a biotech startup. The instructors were friendly and answered my questions quickly, so I walked away feeling ready to take on more senior projects.
Was für ein inspirierender Kurs! Das Advanced‑Programm an der Stanmore School of Business hat mir nicht nur die Grundlagen der Arzneimittelökonomie vermittelt, sondern auch tiefe Einblicke in Health‑Technology‑Assessment‑Methoden gegeben. Durch das praktische Modul zur Erstellung von Kosten‑Nutzen‑Analysen konnte ich sofort ein Projekt für mein Unternehmen in Berlin starten und die Ergebnisse direkt im Board‑Meeting präsentieren. Die Lehrmaterialien waren hervorragend recherchiert, mit aktuellen deutschen und europäischen Richtlinien verknüpft. Ich fühle mich jetzt bestens gerüstet, um komplexe ökonomische Bewertungen zu leiten – ein echter Karriereschub!
The Advanced Drug Economics certificate offered a remarkably detailed learning experience. Each week’s syllabus was meticulously structured: week one covered the theory behind incremental cost‑effectiveness ratios, week two delved into probabilistic sensitivity analysis, and week three focused on real‑world data extraction from national health databases. I applied the R‑script provided in the course to simulate a budget‑impact model for a novel diabetes therapy, which later became a discussion point in my agency’s policy forum. The reading list, featuring both WHO reports and recent peer‑reviewed articles, ensured the content stayed current. The combination of recorded lectures, live Q&A sessions, and peer‑reviewed assignments created a comprehensive environment that solidified my practical skill set.
